Genomic Health Inc. (GHDX)
-NasdaqGS | Prev Close: | 37.21 |
|---|
| Open: | N/A |
|---|
| Bid: | 30.58 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 35.23 |
|---|
| Beta: | 0.34 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 25.25 - 37.47 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 224,948 |
|---|
| Market Cap: | 1.12B |
|---|
| P/E (ttm): | 173.07 |
|---|
| EPS (ttm): | 0.22 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Fri, May 17)
- In Insider Trading, Harbinger Buys Spectrum Brands Stock for 11th Time Since April 9Minyanville(Fri, May 17)
- Hecla Mining CEO Buys 150K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu, May 16)
- The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis PharmaceuticalsZacks(Thu, May 16)
- Genomic Health's New Prostate Test May Extend The Stock's Upward Climbat Seeking Alpha(Wed, May 15)
- New cancer tools allow patients to reconsider chemoat Reuters(Wed, May 15)
- Much Awaited Test Launch by GenomicZacks(Wed, May 15)
- 5 Stocks Insiders Love Right Nowat TheStreet(Wed, May 15)
- An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy StockMinyanville(Wed, May 15)
- U.S. Steel Director Buys More Than 72K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, May 15)
- 3 Disruptive Technologies That Could Slash Health-Care Costsat Motley Fool(Tue, May 14)
- Myriad Genetics climbs after Jolie reveals genetic testingat theflyonthewall.com(Tue, May 14)
- Genomic Gains Coverage for DCISZacks(Mon, May 13)
- GENOMIC HEALTH INC Files SEC form 8-K, Other EventsEDGAR Online(Mon, May 13)
- GENOMIC HEALTH INC FinancialsEDGAR Online Financials(Sat, May 11)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| GHDX | 0.00% | 1.12B |
| TMO | 0.00% | 31.15B |
| WYETH.NS | 0.66% | 18.35B |
| WYETH.BO | 0.41% | 18.24B |
| A | 0.00% | 15.99B |
Key Statistics
| Forward P/E (1 yr): | 124.03 |
|---|
| P/S (ttm): | 4.69 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.05 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.08 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | -21.57 |
|---|
Business Summary
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer,...
View More